| Literature DB >> 32503581 |
Abstract
BACKGROUND: Total ankle arthroplasty has progressed as a treatment option for patients with ankle osteoarthritis. However, no studies have been conducted to evaluate the effect of gender on the outcome. The purpose of the present study was to evaluate outcomes, survivorship, and complications rates of total ankle arthroplasty, according to gender differences.Entities:
Keywords: Ankle osteoarthritis; Clinical outcomes; Gender; Survivorship; Total ankle arthroplasty
Mesh:
Year: 2020 PMID: 32503581 PMCID: PMC7275398 DOI: 10.1186/s13018-020-01731-5
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Comparison of patient demographics between men and women
| Men ( | Women ( | ||
|---|---|---|---|
| 65.4 ± 7.3 (45 to 82) | 63.2 ± 7.2 (47 to 83) | 0.114 | |
| 25.3 ± 2.3 (20.5 to 31.8) | 25.6 ± 2.7 (19.1 to 32.0) | 0.111 | |
| 0.277 | |||
| Primary osteoarthritis | 40 (36.7%) | 31 (36.0%) | |
| Recurrent ankle sprain | 35 (32.1%) | 20 (23.3%) | |
| Post-fracture | 34 (31.2%) | 35 (40.7%) | |
| 90.3 ± 32.6 (48 to 170) | 89.6 ± 32.9 (50 to 174) | 0.887 |
BMI body mass index
*The independent t test was used to analyze age differences in age, BMI, and follow-up duration. The chi-square test was used to analyze differences in preoperative diagnoses. A p value of < 0.05 was considered significant
†The values are given as the mean ± standard deviation, with the range in parentheses
‡The values are given as the number of ankles, with the percentage in parentheses
Clinical outcomes of the men and women groups
| Men ( | Women ( | ||
|---|---|---|---|
| Preoperative | 57.6 ± 14.95 | 58.6 ± 17.36 | 0.907 |
| Final follow-up | 17.6 ± 19.29 | 22.4 ± 21.37 | 0.178 |
| Preoperative | 67.3 ± 11.29 | 65.2 ± 14.63 | 0.669 |
| Final follow-up | 28.3 ± 20.88 | 32.1 ± 23.05 | 0.366 |
| Preoperative | 51.0 ± 13.92 | 52.3 ± 12.54 | 0.573 |
| Final follow-up | 88.3 ± 11.99 | 83.9 ± 15.16 | 0.060 |
| Preoperative | 41.9 ± 15.92 | 46.7 ± 16.45 | 0.149 |
| Final follow-up | 65.2 ± 22.32 | 55.4 ± 25.05 | 0.027 |
| Preoperative | 6.8 ± 1.83 | 7.0 ± 1.61 | 0.534 |
| Final follow-up | 1.7 ± 2.28 | 2.0 ± 2.25 | 0.272 |
| Preoperative | 9.8 ± 6.20 | 9.6 ± 5.44 | 0.877 |
| Final follow-up | 10.5 ± 6.24 | 11.3 ± 5.12 | 0.381 |
| Preoperative | 21.4 ± 10.09 | 23.9 ± 9.94 | 0.138 |
| Final follow-up | 22.8 ± 11.28 | 25.6 ± 9.84 | 0.170 |
AOS Ankle Osteoarthritis Scale, AOFAS American Orthopaedic Foot & Ankle Society, SF-36 PCS Short Form-36 Physical Component Summary, VAS visual analog scale, ROM range of motion
*The independent t test was used to analyze age differences in all variables except range of motion. The Mann-Whitney U test was used to analyze differences in range of motion. A p value of < 0.05 was considered significant
†The values are given as the mean ± standard deviation
Fig. 1The mean preoperative and final follow-up clinical values are shown as bar graphs and the gap between the two values is the improvement value. The error bars indicate standard deviation. AOS, Ankle Osteoarthritis Scale; AOFAS, American Orthopaedic Foot and Ankle Society; SF-36 PCS, Short Form-36 Physical Component Summary; VAS, visual analog scale. *Significant differences in SF-36 PCS scores between the two groups at the final follow-up
Radiographic outcomes of men and women groups
| Men ( | Women ( | ||
|---|---|---|---|
| Preoperative | 8.5 ± 6.6 (− 31.1 to 19.8) | 11.0 ± 6.8 (− 32.0 to 18.4) | 0.020 |
| Final follow-up | 3.6 ± 2.1 (− 10.2 to 3.2) | 4.0 ± 2.2 (− 10.4 to 3.5) | 0.226 |
| Improvement‡ | 4.9 ± 6.3 (− 4.9 to 24.8) | 7.5 ± 6.5 (− 4.2 to 26.8) | 0.014 |
*The independent t test was used to analyze age differences in tibiotalar angle. A p value of < 0.05 was considered significant
†The values are given as the mean ± standard deviation, with the range in parentheses. To reduce errors in the mean calculation due to positive (valgus) and negative (varus) values, these values are calculated as absolute values
‡The improvement is given as the mean difference (preoperative minus final)
Rate of complications associated with total ankle arthroplasty
| Men ( | Women ( | ||
|---|---|---|---|
| 11 (10.1%) | 16 (18.6%) | 0.087 | |
| Deep infection | 1 (0.9%)‡ | - | 1.000 |
| Periprosthetic osteolysis | 10 (9.2%) | 16 (18.6%) | 0.054 |
| Alone | 6 (5.5%) | 11 (12.8%) | 0.073 |
| With aseptic loosening | - | 4 (4.7%)‡ | 0.036 |
| With component subsidence | 4 (3.7%)‡ | 1 (1.2%)‡ | 0.386 |
| 8 (7.3%) | 4 (4.7%) | 0.109 | |
| Wound problem | - | 1 (1.2%) | 0.441 |
| Heterotopic ossification | 8 (7.3%) | 3 (3.5%) | 0.352 |
| 19 (17.4%) | 20 (23.3%) | 0.459 |
*The chi-square or Fisher’s exact test was used to analyze differences in the number of complication. A p value of < 0.05 was considered significant
†The values are given as the number of ankles, with the percentage in parentheses
‡These are failure cases that were revised with an exchange of the metallic component
Fig. 2The Kaplan-Meier curve demonstrates the survivorship of total ankle arthroplasty (195 ankles), when the end point was defined as failure of the prosthesis. The overall survival probability of the implant was 96.1% (96.4% in the men’s group and 93.4% in the women’s group) at the mean follow-up of 7.5 years (p = 0.621)